LeMaitre Vascular (LMAT) Tops Q3 View By 3c
LeMaitre Vascular, Inc. (Nasdaq: LMAT) reports Q3 loss of $0.00, 3 cents better than the analyst estimate of ($0.03). Revenue for the quarter was $12 million, versus the consensus of $11.67 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Infoblox (BLOX) Tops Q3 EPS by 4c; Guides Q4
- Semtech Corp (SMTC) Misses Q1 EPS by 4c; Guides Q2
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
